Search

  • HOME
  • Search
Original Articles
6254
Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance
Soie Kwon, Jin Seong Hyeon, Youngae Jung et al.
Kidney Res Clin Pract. 2023;42(4):445-459.   Published online July 25, 2023
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    PDFSupplementary Material
Review Articles
6181
Novel biomarkers for diabetic kidney disease
Chan-Young Jung, Tae-Hyun Yoo
Kidney Res Clin Pract. 2022;41(Suppl 2):S46-S62.   Published online September 30, 2022
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
Original Articles
6180
Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renal prognosis in patients with diabetic nephropathy
Taeyeong Kim, Yooujin Kwak, Jun Young Lee et al.
Kidney Res Clin Pract. 2022;41(5):545-555.   Published online September 30, 2022
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
6170
Weight change and risk of depression in patients with diabetic kidney disease: a nationwide population-based study
Hong Sang Choi, Bongseong Kim, Kyung-Do Han et al.
Kidney Res Clin Pract. 2023;42(1):86-97.   Published online September 8, 2022
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    PDFSupplementary Material
Review Articles
6156
NADPH oxidase inhibitor development for diabetic nephropathy through water tank model
Hye Eun Lee, Seunghwan Shim, Yongseok Choi, Yun Soo Bae
Kidney Res Clin Pract. 2022;41(Suppl 2):S89-S98.   Published online July 19, 2022
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
6160
Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
Anthony T. P. Chan, Sydney C. W. Tang
Kidney Res Clin Pract. 2022;41(6):682-698.   Published online July 19, 2022
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
6139
GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Ji Hee Yu, So Young Park, Da Young Lee, Nan Hee Kim, Ji A Seo
Kidney Res Clin Pract. 2022;41(2):136-149.   Published online March 25, 2022
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
6127
Exploring molecular targets in diabetic kidney disease
Sayako Maruno, Tetsuhiro Tanaka, Masaomi Nangaku
Kidney Res Clin Pract. 2022;41(Suppl 2):S33-S45.   Published online March 15, 2022
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
Original Articles
6058
Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea
Nam-Jun Cho, Dae-Yeon Kim, Soon Hyo Kwon et al.
Kidney Res Clin Pract. 2021;40(3):383-391.   Published online July 7, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    PDFSupplementary Material
6039
Manifestation of rs1888747 polymorphisms in the FRMD3 gene in diabetic kidney disease and diabetic retinopathy in type 2 diabetes patients
Chatchai Kreepala, Pitirat Panpruang, Rapeeporn Yodprom et al.
Kidney Res Clin Pract. 2021;40(2):263-271.   Published online June 2, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
Nrf2-Heme oxygenase-1 modulates autophagy and inhibits apoptosis triggered by elevated glucose levels in renal tubule cells
Joo-Heon Kim, Kyeong Min Kim, Jin Uk Jeong, Jong Ho Shin, Jae Min Shin, Ki Tae Bang
Kidney Res Clin Pract. 2019;38(3):318-325.   Published online September 30, 2019
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Review Articles
Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease
Mitsuo Kato
Kidney Res Clin Pract. 2018;37(3):197-209.   Published online September 30, 2018
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Pathology identifies glomerular treatment targets in diabetic nephropathy
Charles E. Alpers, Kelly L. Hudkins
Kidney Res Clin Pract. 2018;37(2):106-111.   Published online June 30, 2018
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
The Efficacy of Urinary Albumin-to-Osmolality Ratio in Predicting 24-hour Urine Albumin Excretion in Type 2 DM Patients
Ju Hyun Lee, M.D., So Young Kim, M.D., Min Ji Lee, M.D., Soon Ae Kim, M,D., Sung Joon Shin, M.D. and Kyung Soo Kim, M.D.
Korean J Nephrol. 2011;30(6):601-606.
PDFPDF    
Over-expression of Liver X Receptor- α (LXRα) by TO901317 Exaggerated the Production of Mesangial Matrix
Ho Jun Chin, M.D., Ph.D, Yan Yan Fu, M.D. Young Rim Song, M.D. En Sung Lee Yun Mi Lee Seong Gyun Kim, M.D., Ph.D. Ki Young Na, M.D., Ph.D. Suhnggwon Kim, M.D., Ph.D. and Dong-Wan Chae, M.D., Ph.D.
Korean J Nephrol. 2010;29(2):189-197.
PDFPDF    

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail: registry@ksn.or.kr                

Copyright © 2023 by The Korean Society of Nephrology.

Developed in M2PI

Close layer